Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)

China flag China · Delayed Price · Currency is CNY
32.18
-0.36 (-1.11%)
Nov 11, 2024, 3:00 PM CST
17.32%
Market Cap 29.36B
Revenue (ttm) 8.92B
Net Income (ttm) 2.78B
Shares Out 921.70M
EPS (ttm) 3.03
PE Ratio 10.52
Forward PE 9.63
Dividend 1.30 (4.04%)
Ex-Dividend Date Jun 17, 2024
Volume 9,223,201
Open 32.11
Previous Close 32.54
Day's Range 31.54 - 32.44
52-Week Range 23.85 - 45.18
Beta 0.15
Analysts n/a
Price Target n/a
Earnings Date Oct 23, 2024

About Hubei Jumpcan Pharmaceutical

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese a... [Read more]

Sector Healthcare
CEO Fei Cao
Employees 5,230
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600566
Full Company Profile

Financial Performance

In 2023, Hubei Jumpcan Pharmaceutical's revenue was 9.65 billion, an increase of 7.32% compared to the previous year's 9.00 billion. Earnings were 2.82 billion, an increase of 30.04%.

Financial Statements

News

There is no news available yet.